Abstract:Ara h 2 structure determined in complex with human antibodies. Hypoallergen engineered for reduced IgE binding. Hypoallergen demonstrates reduced anaphylaxis in mice primed with peanut allergic serum. Introduction Adverse reactions are relatively common during peanut oral immunotherapy. To reduce the risk to the patient, some researchers have proposed modifying the allergen to reduce IgE reactivity, creating a putative hypoallergen. Analysis of recently cloned human IgG from patients treated with peanut immunotherapy suggested that there are three common conformational epitopes for the major peanut allergen Ara h 2. We sought to test if structural information on these epitopes could indicate mutagenesis targets for designing a hypoallergen and evaluated the reduction in IgE binding via immunochemistry and a mouse model of passive cutaneous anaphylaxis (PCA). Methods X‐ray crystallography characterized the conformational epitopes in detail, followed by mutational analysis of key residues to modify monoclonal antibody (mAb) and serum IgE binding, assessed by ELISA and biolayer interferometry. A designed Ara h 2 hypoallergen was tested for reduced vascularization in mouse PCA experiments using pooled peanut allergic patient serum. Results A ternary crystal structure of Ara h 2 in complex with patient antibodies 13T1 and 13T5 was determined. Site‐specific mutants were designed that reduced 13T1, 13T5, and 22S1 mAbs binding by orders of magnitude. By combining designed mutations from the three major conformational bins, a hexamutant (Ara h 2 E46R, E89R, E97R, E114R, Q146A, R147E) was created that reduced IgE binding in serum from allergic patients. Further, in the PCA model where mice were primed with peanut allergic patient serum, reactivity upon allergen challenge was significantly decreased using the hexamutant. Conclusion These studies demonstrate that prior knowledge of common conformational epitopes can be used to engineer reduced IgE reactivity, an important first step in hypoallergen design.

Glycosylation Between Recombinant Peanut Protein Ara H 1 and Glucosamine Could Decrease the Allergenicity Due to the Protein Aggregation

Crosslinked Recombinant-Ara H 1 Catalyzed by Microbial Transglutaminase: Preparation, Structural Characterization and Allergic Assessment

Purification and molecular characterization of a truncated-type Ara h 1, a major peanut allergen: oligomer structure, antigenicity, and glycoform

Impacts of glycation and transglutaminase-catalyzed glycosylation with glucosamine on the conformational structure and allergenicity of bovine β-lactoglobulin.

Effect of Glycation Derived from Α-Dicarbonyl Compounds on the in Vitro Digestibility of Ovalbumin: Tracing of Advanced Glycation End-Products and Immuno-Active Peptides

Glycation by saccharides of different molecular sizes affected the allergenicity of shrimp tropomyosin via epitope loss and the generation of advanced glycation end products.

Effects of the covalent conjugation between caffeic acid and peanut allergen protein Ara h1 on the antigenicity and structure of Ara h1

Spectroscopic Studies on Maillard Reactions of Peanut Ara h 2.01 With Respective Reducing Sugars and Their Impacts on Ara h 2.01 Allergenicity

Allergenicity Suppression of Tropomyosin from Exopalaemon Modestus by Glycation with Saccharides of Different Molecular Sizes

Covalent conjugation with (−)-epigallo-catechin 3-gallate and chlorogenic acid changes allergenicity and functional properties of Ara h1 from peanut

Identification of the Immunodominant Epitopes on Ara h1,a Major Peanut Allergen

Crosslinking of peanut allergen Ara h 2 by polyphenol oxidase: digestibility and potential allergenicity assessment.

New insight into the effects of different glycation treatments on the structure and IgG‐binding capacity of α‐lactalbumin

The effects of ultrasound-assisted glycation on the allergenicity and functional properties of peanut proteins

Design of an Ara h 2 hypoallergen from conformational epitopes

Crystal Structure of Ara H 3, a Major Allergen in Peanut.

The conformational epitope of Ara h 5 was crucial to the severe reactivity of peanut allergy

Effect of Boiling on the Structure and Immunoreactivity of Recombinant Peanut Protein Ara H 1

Defining the cross-reactivity between peanut allergens Ara h 2 and Ara h 6 using monoclonal antibodies

Effect of the Structure and Potential Allergenicity of Glycated Tropomyosin, the Shrimp Allergen

Pectin Oligosaccharides Glycosylation Modification Reduced the Sensitization of Shrimp Tropomyosin by Regulating Cytokines Expression and Th1/Th2 Immune Balance